PSL Group Executive and Leadership Team

Michele Fearon, the Chief Executive Officer at PSL Group, directs the overarching corporate strategy and global vision for the organization. Overseeing the integration of pharmaceutical market research with clinical education, Fearon ensures that the company maintains a competitive edge across North American and European markets. This leadership role involves constant collaboration with the Board to refine service delivery models and expand the reach of healthcare communication programs. By aligning internal resources with the evolving needs of consulting agencies, Fearon drives sustainable growth and operational excellence. Michele Fearon maintains a focus on long-term value creation, ensuring that the firm remains a trusted partner for international healthcare clients. Through rigorous oversight of market positioning, Fearon secures the company's status as a leader in the delivery of professional marketing messages and clinical evidence programs.

Neil Corner, the Chief Executive Officer, AI LaunchPad, PSL Group at PSL Group, architects the technological transformation of the firm through advanced artificial intelligence initiatives. Overseeing the development of AI-driven tools, Corner ensures that the company leverages data to enhance pharmaceutical market research and physician engagement. This leadership role involves bridging the gap between complex clinical data and actionable marketing insights for global healthcare agencies. By implementing scalable AI solutions, Corner drives innovation across the organization, ensuring that the firm remains at the forefront of digital healthcare communication. Neil Corner manages the strategic deployment of new technologies to optimize fieldwork services and improve the resonance of educational programs. Through the application of machine learning, Corner enhances the efficiency of PV update programs, ultimately providing clients with superior, evidence-based insights that support informed decision-making in the medical sector.

Tim Houghton, the Chief Executive Officer, MEC Domain at PSL Group, directs the strategic expansion and operational success of the medical education and communication division. Overseeing the creation of programs that combine professional marketing with clinical evidence, Houghton ensures that all educational content resonates effectively with physicians. This leadership role involves managing complex relationships with healthcare communication agencies to deliver high-quality on-label education and PV update programs. By focusing on the intersection of clinical science and market strategy, Houghton drives the development of impactful communication tools that support the broader mission of the firm. Tim Houghton monitors global market trends to ensure that the MEC domain remains responsive to the needs of international clients. Through consistent focus on quality and clinical accuracy, Houghton maintains the reputation of the company as a premier provider of specialized healthcare communication services.

Jim Karr, the Chief Financial Officer at PSL Group, directs the financial health and fiscal strategy of the organization. Overseeing all accounting, budgeting, and financial planning functions, Karr ensures that the company maintains the capital necessary to support its global expansion and technological investments. This leadership role involves providing the Board with accurate financial reporting and risk assessment to guide long-term decision-making. By managing the firm's financial resources, Karr drives the stability required to sustain high-quality pharmaceutical market research and healthcare communication services. Jim Karr works closely with executive leadership to evaluate the profitability of new service lines and international market opportunities. Through disciplined financial management, Karr ensures that the company remains well-positioned to navigate the complexities of the global healthcare market, providing the necessary fiscal foundation for continued growth and innovation in the delivery of clinical evidence programs.

Elizabeth Barron, the Chief Operating Officer at PSL Group, manages the internal infrastructure and administrative efficiency required to support global fieldwork services. Overseeing the daily operations of the firm, Barron ensures that resources are allocated effectively to meet the demands of pharmaceutical market research and consulting clients. This leadership role involves streamlining cross-departmental workflows to enhance the delivery of clinical evidence programs across North America and international regions. By optimizing operational processes, Barron drives productivity and ensures that the company maintains high standards of service quality. Elizabeth Barron coordinates with other C-suite leaders to align operational capacity with the strategic goals of the organization. Through the implementation of robust management systems, Barron supports the firm's ability to scale its services, ensuring that all client projects are executed with precision and reliability in a fast-paced healthcare environment.

Kim Nachbaur, the Executive President, Enterprise Partnerships at PSL Group, directs the development and maintenance of high-level relationships with major pharmaceutical and healthcare communication agencies. Overseeing the enterprise sales strategy, Nachbaur ensures that the company secures long-term partnerships that drive revenue and market share. This leadership role involves identifying new opportunities for collaboration and tailoring the firm's fieldwork and educational services to meet the specific needs of large-scale clients. By fostering deep connections within the industry, Nachbaur drives the growth of the company's enterprise portfolio across international markets. Kim Nachbaur works with the executive team to align partnership goals with the firm's broader mission of delivering clinical evidence and marketing messages. Through strategic account management, Nachbaur ensures that the company remains the preferred partner for organizations seeking to enhance their physician engagement and market research capabilities.

Kristin Stockett, the Executive President, Enterprise Partnerships, Peerdirect at PSL Group, directs the strategic growth of the Peerdirect division through targeted enterprise partnerships. Overseeing the expansion of the Peerdirect network, Stockett ensures that the company connects effectively with healthcare professionals to gather critical market insights. This leadership role involves managing relationships with key industry stakeholders to facilitate the delivery of professional marketing messages and clinical evidence. By focusing on the unique requirements of the Peerdirect platform, Stockett drives the acquisition of new enterprise clients and enhances the value of existing partnerships. Kristin Stockett collaborates with other executive leaders to ensure that the Peerdirect division remains aligned with the firm's overall strategic objectives. Through the development of robust partnership models, Stockett secures the company's position as a leader in physician-focused market research and healthcare communication services.

Jill Myerow, the Group President, Business Unit, Peerscience at PSL Group, directs the scientific integrity and strategic direction of the Peerscience business unit. Overseeing the development of programs that translate complex clinical evidence into actionable marketing insights, Myerow ensures that the firm provides high-quality educational content for physicians. This leadership role involves managing the scientific teams to maintain accuracy and relevance in all PV update programs and on-label education initiatives. By bridging the gap between clinical research and commercial communication, Myerow drives the success of the Peerscience unit in a competitive global market. Jill Myerow works with other business unit leaders to ensure that scientific rigor remains a core component of the company's service offerings. Through the management of specialized scientific projects, Myerow supports the firm's mission to provide evidence-based solutions that resonate with healthcare professionals and consulting agencies.

Stephanie Kennedy-Harris, the Group President at PSL Group, directs the performance and strategic alignment of key business units within the organization. Overseeing the operational and commercial success of these units, Kennedy-Harris ensures that the firm delivers consistent value to pharmaceutical and healthcare communication clients. This leadership role involves coordinating across departments to optimize the delivery of market research and clinical education programs. By focusing on operational excellence and client satisfaction, Kennedy-Harris drives the growth of the company's service portfolio in international markets. Stephanie Kennedy-Harris collaborates with the executive team to refine the firm's market approach and ensure that all business units contribute to the overall mission. Through the management of diverse teams and projects, Kennedy-Harris ensures that the company maintains its reputation for delivering high-impact, evidence-based communication solutions that meet the evolving needs of the global healthcare industry.

Christian Grenon, the Chief Operations Officer at PSL Group, directs the execution of fieldwork services and the logistical delivery of healthcare communication projects. Overseeing the operational teams responsible for data collection and physician engagement, Grenon ensures that all programs meet the rigorous standards of pharmaceutical market research agencies. This leadership role involves managing the technical aspects of fieldwork to ensure accuracy and timeliness in the delivery of clinical evidence. By optimizing the operational framework, Grenon drives efficiency across the company's international offices, ensuring that client needs are met with precision. Christian Grenon collaborates with the technology and strategy teams to integrate new tools into the operational workflow. Through the management of complex project lifecycles, Grenon ensures that the firm consistently delivers high-value insights that help clients communicate effectively with healthcare professionals on a global scale.